Earlier this month, Merck and Daiichi Sankyo announced that ifinatamab deruxtecan was granted Breakthrough Therapy Designation by the U.S. FDA for treating adult patients with extensive-stage small ...

AbbVie's oncology sales climbed 4.2% in H1 2025 as new drugs offset Imbruvica declines, strengthening its long-term growth outlook.

Aurobindo Pharma said it 'regularly explores' various strategic opportunities, including potential acquisitions and ...

A food additive made mass production of brain organoids possible. Researchers can now study development and disease at scale.

The Global Diabetic Neuropathy Market is expected to reach at a CAGR of 6.7% during the forecast period (2024-2031). The ...

TOKYO -- Japanese businesses are busy positioning themselves to soften the blow from the Trump administration's tariffs as the policy focus shifts from country-specific to industry-specific duties.